Genome-wide analysis of mRNA decay in resting and activated primary human T lymphocytes.

We used microarray technology to measure mRNA decay rates in resting and activated T lymphocytes in order to better understand the role of mRNA decay in regulating gene expression. Purified human T lymphocytes were stimulated for 3 h with medium alone, with an anti-CD3 antibody, or with a combination of anti-CD3 and anti-CD28 antibodies. Actinomycin D was added to arrest transcription, and total cellular RNA was collected at discrete time points over a 2 h period. RNA from each point was analyzed using Affymetrix oligonucleotide arrays and a first order decay model was used to determine the half-lives of approximately 6000 expressed transcripts. We identified hundreds of short-lived transcripts encoding important regulatory proteins including cytokines, cell surface receptors, signal transduction regulators, transcription factors, cell cycle regulators and regulators of apoptosis. Approximately 100 of these short-lived transcripts contained ARE-like sequences. We also identified numerous transcripts that exhibited stimulus-dependent changes in mRNA decay. In particular, we identified hundreds of transcripts whose steady-state levels were repressed following T cell activation and were either unstable in the resting state or destabilized following cellular activation. Thus, rapid mRNA degradation appears to be an important mechanism for turning gene expression off in an activation-dependent manner.

[1]  John D. Storey,et al.  Precision and functional specificity in mRNA decay , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  A. Raghavan,et al.  HuA and Tristetraprolin Are Induced following T Cell Activation and Display Distinct but Overlapping RNA Binding Specificities* , 2001, The Journal of Biological Chemistry.

[3]  F. Granucci,et al.  Gene Expression Profiling in Immune Cells Using Microarray , 2001, International Archives of Allergy and Immunology.

[4]  C. Rudd,et al.  CD28 signaling via VAV/SLP-76 adaptors: regulation of cytokine transcription independent of TCR ligation. , 2001, Immunity.

[5]  M. Mann,et al.  AU Binding Proteins Recruit the Exosome to Degrade ARE-Containing mRNAs , 2001, Cell.

[6]  Andreas Rosenwald,et al.  Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol , 2001, Genome Biology.

[7]  Anne F. Buckley,et al.  Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc–dependent pathway , 2001, Nature Immunology.

[8]  C. June,et al.  SAP: natural inhibitor or grand SLAM of T cell activation? , 2001, Nature Immunology.

[9]  C. Akdis,et al.  Mechanisms of interleukin‐10‐mediated immune suppression , 2001, Immunology.

[10]  P. Tamayo,et al.  Cascades of transcriptional induction during human lymphocyte activation. , 2001, European journal of cell biology.

[11]  Tala Bakheet,et al.  ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins , 2001, Nucleic Acids Res..

[12]  R. Siegel,et al.  The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity , 2000, Nature Immunology.

[13]  I. Laird-Offringa,et al.  Post-transcriptional deregulation of myc genes in lung cancer cell lines. , 2000, American journal of respiratory cell and molecular biology.

[14]  M. Rowe,et al.  The bfl-1 Gene Is Transcriptionally Upregulated by the Epstein-Barr Virus LMP1, and Its Expression Promotes the Survival of a Burkitt's Lymphoma Cell Line , 2000, Journal of Virology.

[15]  C. Akdis,et al.  IL‐10 directly acts on T cells by specifically altering the CD28 co‐stimulation pathway , 2000, European journal of immunology.

[16]  R. Pardi,et al.  CD28 and LFA‐1 contribute to cyclosporin A‐resistant T cell growth by stabilizing the IL‐2 mRNA through distinct signaling pathways , 2000, European journal of immunology.

[17]  Y. Shimizu,et al.  From the ECM to the Cytoskeleton and Back: How Integrins Orchestrate T Cell Action , 2000, Developmental immunology.

[18]  R. Cuesta,et al.  Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. , 1999, Science.

[19]  W. Zong,et al.  The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis , 1999 .

[20]  J. Wilusz,et al.  ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system. , 1999, Genes & development.

[21]  J. Opferman,et al.  What keeps a resting T cell alive? , 1999, Cold Spring Harbor symposia on quantitative biology.

[22]  C Gélinas,et al.  The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. , 1999, Genes & development.

[23]  M. Vihinen,et al.  Stimulation of B and T cells activates expression of transcription and differentiation factors. , 1998, Biochemical and biophysical research communications.

[24]  P. Blackshear,et al.  Feedback Inhibition of Macrophage Tumor Necrosis Factor-α Production by Tristetraprolin , 1998 .

[25]  A. Shyu,et al.  RNA stabilization by the AU‐rich element binding protein, HuR, an ELAV protein , 1998, The EMBO journal.

[26]  J. Steitz,et al.  Overexpression of HuR, a nuclear–cytoplasmic shuttling protein, increases the in vivo stability of ARE‐containing mRNAs , 1998, The EMBO journal.

[27]  Van der Luijt,et al.  The genetic analysis of cancer , 1998, Journal of internal medicine.

[28]  M. Billah,et al.  Interleukin-5 mRNA stability in human T cells is regulated differently than interleukin-2, interleukin-3, interleukin-4, granulocyte/macrophage colony-stimulating factor, and interferon-gamma. , 1998, American journal of respiratory cell and molecular biology.

[29]  A. Levy,et al.  Hypoxic Stabilization of Vascular Endothelial Growth Factor mRNA by the RNA-binding Protein HuR* , 1998, The Journal of Biological Chemistry.

[30]  P. Allavena,et al.  Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s , 1998, The Journal of experimental medicine.

[31]  P. Blackshear,et al.  Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. , 1998, Science.

[32]  J. Malter,et al.  Posttranscriptional regulation of mRNAs important in T cell function. , 1998, Advances in immunology.

[33]  C. Y. Chen,et al.  Modulation of the fate of cytoplasmic mRNA by AU-rich elements: key sequence features controlling mRNA deadenylation and decay , 1997, Molecular and cellular biology.

[34]  K. McGowan,et al.  Ectopic expression of Hel-N1, an RNA-binding protein, increases glucose transporter (GLUT1) expression in 3T3-L1 adipocytes , 1997, Molecular and cellular biology.

[35]  D. Postma,et al.  Activation of the cAMP-dependent signaling pathway downregulates the expression of interleukin-3 and granulocyte-macrophage colony-stimulating factor in activated human T lymphocytes. , 1996, Experimental hematology.

[36]  S. Peltz,et al.  Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells. , 1996, Annual review of biochemistry.

[37]  C. Y. Chen,et al.  AU-rich elements: characterization and importance in mRNA degradation. , 1995, Trends in biochemical sciences.

[38]  J. Ross,et al.  mRNA stability in mammalian cells. , 1995, Microbiological reviews.

[39]  Nick Proudfoot,et al.  Expression of the early lymphocyte activation antigen CD69, a C‐type lectin, is regulated by mRNA degradation associated with AU‐rich sequence motifs , 1995, European journal of immunology.

[40]  C. Thompson,et al.  CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. , 1995, Immunity.

[41]  F. Birg,et al.  CD28 costimulation up-regulates long-term IL-2R beta expression in human T cells through combined transcriptional and post-transcriptional regulation. , 1995, Journal of immunology.

[42]  S. Ziegler,et al.  The activation antigen CD69 , 1994, Stem cells.

[43]  G. Crabtree,et al.  Signal transmission between the plasma membrane and nucleus of T lymphocytes. , 1994, Annual review of biochemistry.

[44]  J. Lamb,et al.  CD28 mRNA rapidly decays when activated T cells are functionally anergized with specific peptide. , 1993, International immunology.

[45]  J. Miller,et al.  The CD28 ligand, B7, enhances IL-2 production by providing a costimulatory signal to T cells. , 1992, Journal of immunology.

[46]  C. Thompson,et al.  AU RNA-binding factors differ in their binding specificities and affinities. , 1992, The Journal of biological chemistry.

[47]  R. Reeves,et al.  Stability changes in pim-1 proto-oncogene mRNA after mitogen stimulation of normal lymphocytes. , 1991, Journal of immunology.

[48]  M. Jenkins,et al.  CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. , 1991, Journal of immunology.

[49]  C. Vaquero,et al.  Down-regulation of lck mRNA by T cell activation involves transcriptional and post-transcriptional mechanisms. , 1991, Nucleic acids research.

[50]  C. Thompson,et al.  An inducible cytoplasmic factor (AU-B) binds selectively to AUUUA multimers in the 3' untranslated region of lymphokine mRNA , 1991, Molecular and cellular biology.

[51]  G. Crabtree,et al.  Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. , 1991, Science.

[52]  J. Bishop,et al.  A 3' truncation of MYC caused by chromosomal translocation in a human T-cell leukemia increases mRNA stability. , 1990, Oncogene.

[53]  G. Crabtree,et al.  Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. , 1990, Annual review of immunology.

[54]  R. Schwartz,et al.  Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. , 1990, Journal of immunology.

[55]  C. Thompson,et al.  Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. , 1989, Science.

[56]  G. Crabtree Contingent genetic regulatory events in T lymphocyte activation. , 1989, Science.

[57]  I. Verma,et al.  Removal of an mRNA destabilizing element correlates with the increased oncogenicity of proto-oncogene fos. , 1989, Oncogene research.

[58]  John Calvin Reed,et al.  Induction and regulation of CD2 mRNA in human lymphocytes. , 1988, Journal of immunology.

[59]  G. Shaw,et al.  A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation , 1986, Cell.

[60]  T. Curran,et al.  Removal of a 67-base-pair sequence in the noncoding region of protooncogene fos converts it to a transforming gene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.